Literature DB >> 25607433

Rituximab or azathioprine maintenance in ANCA-associated vasculitis.

Christian Pagnoux, Loïc Guillevin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25607433     DOI： 10.1056/NEJMc1414728

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients.

Authors:  Jens Thiel; Marta Rizzi; Marie Engesser; Ann-Kathrin Dufner; Arianna Troilo; Raquel Lorenzetti; Reinhard E Voll; Nils Venhoff
Journal:  Arthritis Res Ther       Date:  2017-05-18       Impact factor: 5.156

2.  Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study.

Authors:  Julien Demiselle; Johann Auchabie; François Beloncle; Philippe Gatault; Steven Grangé; Damien Du Cheyron; Jean Dellamonica; Sonia Boyer; Dimitri Titeca Beauport; Lise Piquilloud; Julien Letheulle; Christophe Guitton; Nicolas Chudeau; Guillaume Geri; François Fourrier; René Robert; Emmanuel Guérot; Julie Boisramé-Helms; Pierre Galichon; Pierre-François Dequin; Alexandre Lautrette; Pierre-Edouard Bollaert; Ferhat Meziani; Loïc Guillevin; Nicolas Lerolle; Jean-François Augusto
Journal:  Ann Intensive Care       Date:  2017-04-05       Impact factor: 6.925

3.  Rituximab for auto-immune alveolar proteinosis, a real life cohort study.

Authors:  Berenice Soyez; Raphael Borie; Cedric Menard; Jacques Cadranel; Leonidas Chavez; Vincent Cottin; Emmanuel Gomez; Sylvain Marchand-Adam; Sylvie Leroy; Jean-Marc Naccache; Hilario Nunes; Martine Reynaud-Gaubert; Laurent Savale; Abdellatif Tazi; Lidwine Wemeau-Stervinou; Marie-Pierre Debray; Bruno Crestani
Journal:  Respir Res       Date:  2018-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.